During the past decade, Robert Roessle Klinik conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Robert Roessle Klinik" #1 collaborator was "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Robert Roessle Klinik" are "Melanoma (Skin)" (3 trials), "Sarcoma" (2 trials), "Endometrial Cancer" (1 trials), "Esophageal Cancer" (1 trials) and "Gastric Cancer" (1 trials). Many other conditions were trialed in "Robert Roessle Klinik" in a lesser frequency.

Most popular intervention types in "Robert Roessle Klinik" are "Drug" (5 trials), "Biological" (4 trials), "Procedure" (4 trials), "Genetic" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (2 trials), "cisplatin" (2 trials), "recombinant interferon alfa" (2 trials), "Gene-modified (GM) T cell therapy" (1 trials) and "JCAR017" (1 trials). Other intervention names were less common.

The vast majority of trials in "Robert Roessle Klinik" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Robert Roessle Klinik". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Robert Roessle Klinik, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Robert Roessle Klinik, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".